Induction of target antigens and conversion to susceptible phenotype of NK-cell-resistant lymphoid cell line
✍ Scribed by Edward A. Clark; Jerrilyn C. Sturge; Laurence A. Falk Jr.
- Book ID
- 102867123
- Publisher
- John Wiley and Sons
- Year
- 1981
- Tongue
- French
- Weight
- 732 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Two autologous Herpesvirus papio producer lymphoid cell lines and one autologous non‐producer line were compared for susceptibility to natural killer (NK) cell‐mediated lysis. The non‐producer cell line, 26CB‐1, was more resistant to NK cell killing compared to one viral producer counterpart 13CB‐1, but equally resistant when compared to another, 8CB‐1. Treatment with chemical agents that affect differentiation or activate the viral cycle, including n‐butyrate, luDR, 5‐azacytidine and tunicamycin, increased the susceptibility to killing of the non‐producer line but had less effect on the 13CB‐1 producer line. The increase in susceptibility was due to induction of new target antigens: activated 26CB‐1 cells were more effective at inhibiting NK‐cell‐mediated lysis and were bound by more NK cells than untreated control cells. The expression of NK target structures may be related to the differentiated state rather than to the viral production status of target cells.
📜 SIMILAR VOLUMES
## Abstract Most leukemias that exhibit P‐glycoprotein (P‐gp)‐associated multidrug resistance (MDR) exhibit reduced susceptibility to immune cytotoxicity mediated by natural killer (NK) cells. To explore this phenomenon we investigated N6/ADR, a doxorubicin‐selected, P‐gp‐positive variant of the hu
## Abstract Delayed cutaneous hypersensitivity reactions to standard recall antigens (candidin, mumps and PPD), to crude membrane extracts of a cell line derived from Burkitt's lymphoma (Raji) and to a cell line derived from normal lymphocytes (F265) were sequentially evaluated in 44 patients with
## Abstract Hepatic stellate cells (HSCs) are the major site of retinol (ROH) metabolism and storage. GRX is a permanent murine myofibroblastic cell line, derived from HSCs, which can be induced to display the fat‐storing phenotype by treatment with retinoids. Little is known about hepatic or serum